Business Segments (Tables)

6 Months Ended

Jan. 01, 2017

Segment Reporting [Abstract]

Operating Results and Other Financial Information by Segment

Operating results and certain other financial information about the Company’s two reportable segments for the second quarters and first two quarters of fiscal years 2017 and 2016 were as follows:

	For the Second Quarter of Fiscal Year 2017
	MDS			ECP		Unallocated			Eliminations			Total
Net sales	$	67,382		$	32,350	$	—		$	(2,333	)	$	97,399
Gross profit	8,357			7,541		—			—			15,898
Selling and administrative expenses (incl. depreciation)	5,561			3,545		3,847			—			12,953
Internal research and development expenses	—			533		—			—			533
Operating income	986			3,082		(3,847		)	—			221
Capital expenditures	464			423		564			—			1,451
Total assets at January 1, 2017	$	151,020		$	63,143	$	9,009		$	—		$	223,172
	For the Second Quarter of Fiscal Year 2016
	MDS			ECP		Unallocated			Eliminations			Total
Net sales	$	67,586		$	40,642	$	—		$	(4,699	)	$	103,529
Gross profit	6,989			11,532		—			—			18,521
Selling and administrative expenses (incl. depreciation)	6,646			3,715		3,979			—			14,340
Internal research and development expenses	—			438		—			—			438
Restructuring charges	2,360			—		—			—			2,360
Reversal of accrued contingent consideration	(1,530		)	—		—			—			(1,530		)
Operating income (loss)	(2,524		)	6,957		(3,979		)	—			454
Capital expenditures	427			228		1,128			—			1,783
Total assets at July 3, 2016	$	167,277		$	69,627	$	9,094		$	—		$	245,998
	For the First Two Quarters of Fiscal Year 2017
	MDS			ECP		Unallocated			Eliminations			Total
Net sales	$	132,384		$	69,942	$	—		$	(4,560	)	$	197,766
Gross profit	15,651			17,532		—			—			33,183
Selling and administrative expenses (incl. depreciation)	11,537			7,369		7,430			—			26,336
Internal research and development expenses	—			884		—			—			884
Operating income	472			8,511		(7,430		)	—			1,553
Capital expenditures	$	670		$	758	$	1,142		$	—		$	2,570
	For the First Two Quarters of Fiscal Year 2016
	MDS			ECP		Unallocated			Eliminations			Total
Net sales	$	141,543		$	78,731	$	—		$	(10,054	)	$	210,220
Gross profit	17,285			22,374		—			—			39,659
Selling and administrative expenses (incl. depreciation)	12,527			7,312		8,125			—			27,964
Internal research and development expenses	—			951		—			—			951
Restructuring charges	2,360			—		—			—			2,360
Reversal of accrued contingent consideration	(1,530		)	—		—			—			(1,530		)
Operating income (loss)	(183		)	13,260		(8,125		)	—			4,952
Capital expenditures	$	1,433		$	273	$	1,557		$	—		$	3,263